Overall, our study elucidates the mechanistic underpinnings of RFWD3 regulation in DDP resistance and suggests that targeting RFWD3 and its associated metabolic pathways represents a promising strategy for osteosarcoma treatment. Here, RFWD3 is linked to osteosarcoma.